MOTS-c: mitochondrial signaling research in context
How to understand a mitochondrial-derived peptide as an active research topic, not a shortcut to a health claim.
Educational information only — not medical advice. This page does not diagnose conditions, recommend treatment, or replace care from a qualified clinician. The Peptide Center uses an evidence-first editorial process: regulatory sources, trial registries, and peer-reviewed research take priority; uncertainty is stated rather than filled with promises.
MOTS-c is a mitochondrial-derived peptide studied in metabolism and cellular-stress research. The field is scientifically active, but active research is not a substitute for reliable evidence in people. Findings from model systems often identify questions worth testing; they rarely settle questions about real-world benefit or safety.
External sources and citations
- Therapeutic peptides: recent advances in discovery, synthesis, and clinical applications. Signal Transduction and Targeted Therapy, 2022
- ClinicalTrials.gov: Learn about studies
- FDA: The drug development process
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
5-Amino-1MQ
An evidence-first reference for reading claims and source material about 5-Amino-1MQ.
Open resourcePeptide brief5-Amino-1MQ / SLU-PP-332
An evidence-first reference for reading claims and source material about 5-Amino-1MQ / SLU-PP-332.
Open resourcePeptide briefAOD-9604
An evidence-first reference for reading claims and source material about AOD-9604.
Open resourcePeptide briefAOD-9604: interpreting a fragment-peptide claim
A framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.
Open resourcePeptide briefATX-304
An evidence-first reference for reading claims and source material about ATX-304.
Open resourcePeptide briefB7-33: an early-stage research overview
Why preclinical pathway research should not be confused with an established intervention.
Open resourceArticleFDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Open resourceArticleAn ingredient name is not a complete product
Why matching a molecule name does not establish sameness in approval, formulation, quality, or evidence.
Open resource